Characterizing short-term release and neovascularization potential of multi-protein growth supplement delivered via alginate hollow fiber devices

Biomaterials

Volumn 28, Issue 1, 2007, Pages 89-98

  Tilakaratne, H K ^a,b   Hunter, Stephen K ^a,c   Andracki, Mark E ^c   Benda, Jo A ^c   Rodgers, V G J ^a,b  

^a IA United States   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Alginate; Controlled release; ECGS; Growth factors; Modeling; Neovascularization

Indexed keywords

CONTROLLED RELEASE; ENDOTHELIAL CELL GROWTH; GROWTH FACTORS; NEOVASCULARIZATION;

BIOCHEMISTRY; CELLS; CONTROLLED DRUG DELIVERY; GELS; POLYPROPYLENES; POLYSACCHARIDES; TISSUE; TRANSPLANTATION (SURGICAL);

PROTEINS;

ALGINIC ACID; ANGIOGENIC FACTOR; CALCIUM ALGINATE; ENDOTHELIAL CELL GROWTH FACTOR; GROWTH FACTOR; MULTIPROTEIN COMPLEX; POLYPROPYLENE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL ORGAN; BIOCHEMISTRY; CELL TRANSPLANTATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DEVICE; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; HOLLOW FIBER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STIMULUS RESPONSE; VASCULARIZATION;

ALGINATES; ANIMALS; CALCIUM; DRUG DELIVERY SYSTEMS; ENDOTHELIAL CELLS; GLUCURONIC ACID; HEXURONIC ACIDS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MOLECULAR WEIGHT; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; TIME FACTORS;

EID: 33748883100     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2006.08.011     Document Type: Article

References (50)

1. Woodward S.C. How fibroblasts and giant cells encapsulate implants: considerations in design of glucose sensors. Diabetes Care 5 (1982) 278-281
2. Hoffman D., Breakefield X.O., Short M.P., and Aebischer P. Transplantation of a polymer-encapsulated cell line genetically engineered to release NGF. Exp Neurol 122 (1993) 100-106
3. Unger R.E., Huang Q., Peters K., Protzer D., Paul D., and Kirkpatrick C.J. Growth of human cells on polyethersulfone (PES) hollow fiber membranes. Biomaterials 26 14 (2005) 1877-1884
4. O'Shea G.M., Goosen M.F.A., and Sun A.M. Prolonged survival of transplanted islets of Langerhans encapsulated in a biocompatible membrane. Biochim Biophys Acta 804 (1984) 133-136
5. Lanza R.P., Butler D.H., Borland K.M., Staruk J.E., Faustman D.L., Solomon B.A., et al. Xenotransplantation of canine, bovine, and porcine islets in diabetic rats without immunosuppression. Proc Natl Acad Sci 88 (1991) 11100-11104
6. Zekorn T., Renardy M., Planck H., Zschocke P., Bretzel R.G., Siebers U., et al. Experiments on a hollow fiber membrane for immunoisolated transplantation of islets of Langerhans. Horm Metab Res 25 (1990) 202-206 (Suppl S)
7. Brauker J., Martinson L.A., Young S.K., and Johnson R.C. Local inflammatory response around diffusion chambers containing xenografts. Transplantation 61 (1996) 1671-1677
8. Aebischer P., Ip T.K., Miracoli L., and Galleti P.M. Renal epithelial cells grown on semipermeable hollow fibers as a potential ultrafiltrate processor. Trans Am Soc Artif Intern Organs 33 (1987) 96-102
9. De Vos P., Hillebrands J.-L., De Haan B.J., Strubbe J.H., and Van Schilfgaarde R. Efficacy of a prevascularized expanded polytetrafluoroethylene solid support system as a transplantation site for pancreatic islets. Transplantation 63 6 (1997) 824-830
10. Colton C.K., and Avgoustiniatos E.S. Bioengineering in development of the hybrid artificial pancreas. Trans ASME 113 (1991) 152-170
11. Colton C.K. Implantable biohybrid artificial organs. Cell Transplant 4 (1995) 415-436
12. Brauker J.H., Carr-Brendel V.E., Martinson L.A., Crudele J., Johnston W.D., and Johnson R.C. Neovascularization of synthetic membranes directed by membrane microarchitecture. J Biomed Mater Res 29 (1995) 1517-1524
13. Ward W.K., Quinn M.J., Wood M.D., Tiekotter K.L., Pidikiti S., and Gallagher J.A. Vascularizing the tissue surrounding a model biosensor: how localized is the effect of a subcutaneous infusion of vascular endothelial growth factor (VEGF)?. Biosensors Bioelectron 19 3 (2003) 155-163
14. Sieminski A.L., and Gooch K.J. Biomaterial-microvasculature interactions. Biomaterials 21 (2000) 2233-2241
15. Maciag T., Cerundolo J., Ilsley S., Kelley P.R., and Forand R. An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization. Proc Natl Acad Sci USA 76 (1979) 5674-5678
16. Maciag T., Hoover G.A., and Weinstein R. High and low molecular weight forms of endothelial cell growth factor. J Biol Chem 257 (1982) 5333-5336
17. Hunter S.K., Kao J.M., Wang Y., Benda J.A., and Rodgers V.G.J. Promotion of neovascularisation around hollow fiber bioartificial organs using biologically active substances. ASAIO J 45 (1999) 37-40
18. Elçin Y.M., Dixit V., and Gitnick G. Extensive in vivo angiogenesis following controlled release of human vascular endothelial cell growth factor: implication for tissue engineering and wound healing. Artif Organs 25 (2001) 558-565
19. Trivedi N., Steil G.M., Colton C.K., Bonner-Weir S., and Weir G.C. Improved vascularization of planar membrane diffusion devices following continuous infusion of vascular endothelial growth factor. Cell Transplant 9 (2000) 115-124
20. Kawakami Y., Iwata H., Gu Y.J., Miyamoto M., Murakami Y., Balamurugan A.N., et al. Successful subcutaneous pancreatic islet transplantation using an angiogenic growth factor-releasing device. Pancreas 23 (2001) 375-381
21. Lee K.Y., Peters M.C., and Mooney D.J. Comparison of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in SCID mice. J Control Rel 87 1-3 (2003) 49-56
22. Gu F., Amsden B., and Neufeld R. Sustained delivery of vascular endothelial growth factor with alginate beads. J Control Rel 96 3 (2004) 463-472
23. Folkman J. Clinical applications of research on angiogenesis. N Engl J Med 333 (1995) 1757-1763
24. Zisch A.H., Schenk U., Schense J.C., Sakiyama-Elbert S.E., and Hubbell J.A. Covalently conjugated VEGF-fibrin matrices for endothelialization. J Control Rel 72 (2001) 101-113
25. King T.W., and Patrick C.W. Development and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(dl-lactic-co-glycolic acid)/poly(ethylene glycol) microspheres using a solid encapsulation/single emulsion/solvent extraction technique. J Biomed Mater Res 51 (2000) 383-390
26. Peters M.C., Isenberg B.C., Rowley J.A., and Mooney D.J. Release from alginate enhances the biological activity of vascular endothelial growth factor. J Biomater Sci Polymer Ed 9 (1998) 1267-1278
27. Lanza R.P., Butler D.H., Borland K.M., Staruk J.E., Faustman D.L., Solomon B.A., et al. Xenotransplantation of canine, bovine, and porcine islets in diabetic rats without immunosuppression. Proc Natl Acad Sci 88 (1991) 11100-11104
28. Ko C.Y., Dixit V., Shaw W.W., and Gitnick G. Extensive in vivo angiogenesis from the controlled release of endothelial cell growth factor: implications for cell transplantation and wound healing. J Control Rel 44 (1997) 209-214
29. Edelman E.R., Nathan A., Katada M., Gates J., and Karnovsky M.J. Perivascular graft heparin delivery using biodegradable polymer wraps. Biomaterials 21 (2000) 2279-2286
30. Coromili V., and Chang T.M.S. Polydisperse dextran as a diffusing test solute to study the membrane permeability of alginate polylysine microcapsules. Biomater Art Cells Immob Biotechnol 21 (1993) 427-444
31. Dionne K.E., Cain B.M., Li R.H., Bell W.J., Doherty E.J., Rein D.H., et al. Transport characterization of membranes for immunoisolation. Biomaterials 17 (1996) 257-266
32. Itakura J., Ishiwata T., Freiss H., Fuji H., Matsumoto Y., Buchler M.W., et al. Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression. Clin Cancer Res 3 (1997) 1309
33. Fournier N., and Doillon C.J. Biological molecule-impregnated polyester: an in vivo angiogenesis study. Biomaterials 17 (1996) 1659-1665
34. Maciag T., Hoover G.A., and Weinstein R. High and low molecular weight forms of endothelial cell growth factor. J Biol Chem 257 10 (1982) 5333-5336
35. Pronova TM. Alginate information sheet. Pronova Biomedical a.s., Oslo, Norway.
36. Wang X., and Spencer H.G. Calcium alginate gels: formation and stability in the presence of an inert electrolyte. Polymer 39 (1998) 2759-2764
37. Li R.H., Altreuter D.H., and Gentile F.T. Transport characterization of hydrogel matrices for cell encapsulation. Biotechnol Bioeng 50 (1996) 365-373
38. Skjåk-Bræk G., Grasdalen H., and Smidsrød O. Inhomogeneous polysaccharide ionic gels. Carbohydrate Polym 10 (1989) 31-54
39. Degrassi A., Toffanin R., Paoletti S., and Hall L.D. A better understanding of the properties of alginate solutions and gels by quantitative magnetic resonance imaging (MRI). Carbohydrate Res 306 (1998) 19-26
40. Chicheportiche D., and Reach G. In vitro kinetics of insulin release by microencapsulated rat islets: effect of the size of the microcapsules. Diabetologia 31 (1988) 54-57
41. Amsden B., and Turner N. Diffusion characteristics of calcium alginate gels. Biotechnol Bioeng 65 (1999) 605-610
42. Ko C., Dixit V., Shaw W., and Gitnick G. In vitro slow release profile of endothelial cell growth factor immobilized within calcium alginate microbeads. Art Cells Blood Subs Immob Biotechnol 23 (1995) 143-151
43. 2+-alginate gel dissolution on release of dextran with different molecular weights. J Control Rel 58 (1999) 21-28
44. Theodorou N.A., and Howell S.L. An assessment of diffusion chambers for use in pancreatic islet cell transplantation. Transplantation 27 (1979) 350-353
45. Padera R.F., and Colton C.K. Time course of membrane microarchitecture-driven neovascularization. Biomaterials 17 (1996) 277-284
46. Wake M.C., Patrick C.W., and Mikos A.G. Pore morphology effects on the fibrovascular tissue growth in porous polymer substrates. Cell Transplant 3 (1994) 339-343
47. Prokop A., Kozlov E., Nun Non S., Dikov M.M., Sephel G.C., Whitsitt J.S., et al. Towards retrievable vascularized bioartificial pancreas: induction and long-lasting stability of polymeric mesh implant vascularized with the help of acidic and basic fibroblast growth factors and hydrogel coating. Diabetes Technol Ther 3 (2001) 245-261
48. Clark H., Barbari T.M., Stump K., and Rao G. Histologic evaluation of the inflammatory response around implanted hollow fiber membranes. J Biomed Mater Res 52 (2000) 183-192
49. Fournier R.L. Basic transport phenomena in biomedical engineering (1999), Taylor & Francis, Philadelphia, PA (p. 28, 212)
50. Orlowski T., Tatarkiewicz K., Sitarek E., Sabat M., Fiedor P., and Samsel R. Experience with pancreas islets separation, immunoisolation and cryopreservation. Ann Transplant 1 (1996) 54-58